For research use only. Not for therapeutic Use.
Pregomisin is a novel pharmaceutical compound under investigation for its potential therapeutic benefits. Early studies suggest it may be effective in treating certain neurological disorders by modulating synaptic activity. While still in the experimental stage, Pregomisin shows promise, with researchers optimistic about its future applications. Ongoing clinical trials will determine its safety and efficacy for widespread use.
Catalog Number | R030149 |
CAS Number | 66280-26-0 |
Molecular Formula | C22H30O6 |
Purity | ≥95% |
Target | Platelet-activating Factor Receptor (PAFR) |
IUPAC Name | 5-[(2S,3R)-4-(3-hydroxy-4,5-dimethoxyphenyl)-2,3-dimethylbutyl]-2,3-dimethoxyphenol |
InChI | InChI=1S/C22H30O6/c1-13(7-15-9-17(23)21(27-5)19(11-15)25-3)14(2)8-16-10-18(24)22(28-6)20(12-16)26-4/h9-14,23-24H,7-8H2,1-6H3/t13-,14+ |
InChIKey | RLRKIWSBYUZHIJ-OKILXGFUSA-N |
SMILES | CC(CC1=CC(=C(C(=C1)OC)OC)O)C(C)CC2=CC(=C(C(=C2)OC)OC)O |